CA2065450A1 - Derives de substitution de 2-aminotetralines - Google Patents

Derives de substitution de 2-aminotetralines

Info

Publication number
CA2065450A1
CA2065450A1 CA002065450A CA2065450A CA2065450A1 CA 2065450 A1 CA2065450 A1 CA 2065450A1 CA 002065450 A CA002065450 A CA 002065450A CA 2065450 A CA2065450 A CA 2065450A CA 2065450 A1 CA2065450 A1 CA 2065450A1
Authority
CA
Canada
Prior art keywords
group
oxygen
compound
propyl
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002065450A
Other languages
English (en)
Inventor
James V. Peck
Gevork Minaskanian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WHITLY RESEARCH Inc
Whitby Research Inc
Nelson Research and Development Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2065450A1 publication Critical patent/CA2065450A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002065450A 1989-07-05 1990-07-02 Derives de substitution de 2-aminotetralines Abandoned CA2065450A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37558389A 1989-07-05 1989-07-05
US375,583 1989-07-05

Publications (1)

Publication Number Publication Date
CA2065450A1 true CA2065450A1 (fr) 1991-01-06

Family

ID=23481446

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002065450A Abandoned CA2065450A1 (fr) 1989-07-05 1990-07-02 Derives de substitution de 2-aminotetralines

Country Status (4)

Country Link
EP (1) EP0463119A4 (fr)
AU (1) AU6072090A (fr)
CA (1) CA2065450A1 (fr)
WO (1) WO1991000727A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382596A (en) * 1993-08-05 1995-01-17 Whitby Research, Inc. Substituted 2-aminotetralins
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
SV2001000202A (es) * 1999-10-20 2001-10-16 Warner Lambert Co Uso de (-)-5-ceto-2-n,n-d1-n-propilamino-tetrahidrotetralina para el tratamiento del mal de parkinson
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
US7829587B2 (en) 2008-01-09 2010-11-09 Allergan, Inc. Substituted 2-aminotetralin derivatives as selective alpha 2B agonist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930022A (en) * 1972-07-03 1975-12-30 Squibb & Sons Inc Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols
US4267373A (en) * 1972-07-03 1981-05-12 E. R. Squibb & Sons, Inc. 5,6,7,8-Tetrahydronaphthalene hypotensive agents
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
DE3062971D1 (en) * 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
US4882352A (en) * 1986-07-28 1989-11-21 Nelson Research & Development Co. Method for treating schizophrenia
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4885308A (en) * 1984-08-13 1989-12-05 Nelson Research & Development Co. Method and compositions for treatment of parkinsonism syndrome in mammals

Also Published As

Publication number Publication date
AU6072090A (en) 1991-02-06
EP0463119A1 (fr) 1992-01-02
WO1991000727A1 (fr) 1991-01-24
EP0463119A4 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
AU654653B2 (en) Therapeutically useful 2-aminotetralin derivatives
US5118704A (en) Substituted 2-aminotetralins useful as dopaminergics
AU695891B2 (en) Heterocyclic derivatives of N-phenylamides
KR100207876B1 (ko) 치료학적으로 유용한 2-아미노테트랄린 유도체
AU653197B2 (en) Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
CZ299774B6 (cs) Nové piperazinové a piperidinové slouceniny, zpusob jejich prípravy a jejich použití
AU2005250197A1 (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
AU2008344922A2 (en) Chromane derivatives as TRPV3 modulators
CA2065450A1 (fr) Derives de substitution de 2-aminotetralines
CN1181070A (zh) 有治疗作用的二环异硫脲衍生物
US5274003A (en) Substituted 2-aminotetralins
JP2868897B2 (ja) ハロゲン置換アミノテトラリン類
US5358971A (en) Substituted 2-aminotetralins
Natsuka et al. Synthesis and structure-activity relationships of 1-substituted 4-(1, 2-diphenylethyl) piperazine derivatives having narcotic agonist and antagonist activity
JPH0331244A (ja) 新規２，５‐ジアミノテトラリン、その製法及びその製剤組成物としての使用
HU187789B (en) Process for preparing 2-amino-1,2,3,4-tetrahydro-naphtalena derivatives
EP0298703B1 (fr) Dérivé de thiophène et procédé de préparation
GB2123410A (en) New derivatives of 1,2,3,4-tetrahydronaphthalene, process for their preparation and associated pharmaceutical compositions
JP4608160B2 (ja) 新規なフッ素化ベンゾジオキサンイミダゾリン誘導体、それらの製造方法およびそれらの治療用途
AU608768B2 (en) Aryloxycycloalkanolamines
WO1991003459A1 (fr) 2-aminotetralines substituees utilisables comme dopaminergiques
EP0703229A2 (fr) Procédé pour la préparation de 3-amino-5-méthoxychromanne
AU9751798A (en) Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
ANAN et al. 4-(3, 4-Dihydroxyphenyl)-1, 2, 3, 4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship
Stjernlöf et al. 5-, 6-, 7-and 8-amino-2-(N, N-di-n-propylamino)-1, 2, 3, 4-tetrahydronaphthalenes: centrally acting DA and 5-HT1A agonists

Legal Events

Date Code Title Description
FZDE Dead